Harrow (HROW) Other Non-Current Assets (2012 - 2022)
Harrow (HROW) posted Other Non-Current Assets of $2.0 million for Q4 2022, up 875.0% on a QoQ basis from $200000.0 in Q3 2021.
Analysis
Harrow (HROW) Other Non-Current Assets (2012 - 2022) Analysis & Trends
Harrow has reported Other Non-Current Assets for 7 years, with the latest figure at $2.0 million in Q4 2022.
- On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $2.0 million in Q4 2022; TTM through Dec 2022 was $2.0 million, a N/A change from a year earlier, with the FY2022 full-year figure at $2.0 million, changed N/A from the prior year.
- Other Non-Current Assets was $2.0 million for Q4 2022 at Harrow, up from $200000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $2.0 million in Q4 2022, with the low at $200000.0 in Q1 2018.
- Average Other Non-Current Assets over 5 years is $309375.0, with a median of $200000.0 recorded in 2018.
- The largest YoY upside for Other Non-Current Assets was 0.0% in 2018 against a maximum downside of 68.3% in 2018.
- Over 5 years, Other Non-Current Assets stood at $200000.0 in 2018, then changed by 0.0% to $200000.0 in 2019, then changed by 0.0% to $200000.0 in 2020, then changed by 0.0% to $200000.0 in 2021, then jumped by 875.0% to $2.0 million in 2022.
- The last three Other Non-Current Assets figures came in at $2.0 million (Q4 2022), $200000.0 (Q3 2021), and $200000.0 (Q2 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 9.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 5.50 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | 42.45 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 86.76 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 239.50 Mn |
| 10 | Harrow | 1.42 Bn | 1.33 Bn | 50.36 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Mar 31, 2021 | 200,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Sep 30, 2020 | 200,000.00 |
| Jun 30, 2020 | 200,000.00 |
| Mar 31, 2020 | 200,000.00 |
| Dec 31, 2019 | 200,000.00 |
| Sep 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 200,000.00 |
| Mar 31, 2019 | 200,000.00 |
| Dec 31, 2018 | 200,000.00 |
| Sep 30, 2018 | 200,000.00 |
| Jun 30, 2018 | 200,000.00 |
| Mar 31, 2018 | 200,000.00 |
| Dec 31, 2017 | 200,000.00 |
| Sep 30, 2017 | 631,000.00 |
| Jun 30, 2017 | 631,000.00 |
| Dec 31, 2012 | 596,281.00 |